SUMMARY A patient with viral hepatitis in the third trimester of pregnancy is described. She developed acute hepatic failure in the postpartum period which was associated with evidence of intravascular coagulation. Following therapy with heparin and fresh-frozen plasma, the patient made a dramatic recovery. Hepatitis developed during the puerperium may predispose to pathological intravascular coagulation and hepatocellular necrosis may thereby be perpetuated.
Disseminated intravascular coagulation is being detected in an increasing spectrum of clinical situations. Obstetric accidents (abruptio placentae, amniotic fluid embolism, and intrauterine foetal death) and metastatic malignant tumours are well recognized as predisposing to the syndrome. More recently the contribution of intravascular coagulation to the disordered haemostatic situation in parenchymatous liver disease has been appreciated (Rake, Flute, Pannell, and Williams, 1970) . Although fibrin deposition and vascular thrombosis are frequently inconspicuous, the subsequent consumption of platelets, coagulation factors, and plasminogen may lead to a severe haemorrhagic state. The treatment of pathological intravascular coagulation by infusion of heparin has been shown to be of value in the defibrination syndrome (Verstraete, Vermylen, Vermylen, and Vandenbroucke, 1965) . Rake, Flute, Shilkin, Lewis, Winch, and Williams (1971) have recently documented four patients with fulminant hepatic failure complicated by intravascular coagulation who recovered after intensive heparin therapy. This report describes a patient with viral hepatitis of late pregnancy who, in the immediate postpartum period, developed acute hepatic failure with evidence of intravascular coagulation and made a dramatic recovery following heparin therapy.
Methods
The following blood coagulation investigations were performed on admission, before therapy: prothrombin time (results expressed as British ratio), partial ' In receipt of a long-term grant from the Medical Research Council. Received for Publication 26 July 1973. thromboplastin time, factor VII assay, thrombin time, fibrinogen (clot opacity) and euglobulin lysis time using the techniques described by Thomson (1970) .
Fibrin/fibrinogen breakdown products (FDP) were measured by a staphylococcal clumping technique (Leavelle, Mertens, Bowie, and Owen, 1971 The rate of the continuous heparin infusion was subsequently controlled by daily plasma recalcification times, and the progress of the patient during heparin therapy was monitored by serial prothrombin and partial thromboplastin times, FDP, quantitative fibrinogen levels (Ratnoff and Menzie, 1951) , and platelet counts in addition to biochemical parameters.
Case Report
The patient, a 30-year-old English woman, presented in hepatic precoma (grade II-III) on the day following the successful completion of her third pregnancy.
She had been well throughout the antenatal period until some 11 days before delivery when she became anorexic and complained of malaise and nausea. Within two days, her sclerae had become faintly icteric and her stools were pale; the urine was not, however, bile-stained. During this period she remained apyrexial with no disturbance of her conscious state. Labour occurred spontaneously during the thirty-ninth week of pregnancy with a normal vaginal delivery of a healthy male infant. Pethidine 100 mg and Promazine 100 mg together with nitrous oxide were administered during labour.
In the immediate postpartum period, the jaundice deepened and the patient was noted to be excessively drowsy.
At The coagulation studies in this patient are of particular interest, for although no overt haemorrhagic state developed, the tests performed during the period of hepatic insufficiency revealed marked abnormalities. The depression of fibrinogen levels, absence of the normal puerperal elevation of the platelet count, and the gross increase in the fibrin breakdown products (FDP) all suggest that marked intravascular coagulation with secondary local fibrinolysis was present. There was no evidence for primary pathological fibrinolysis as an explanation of the rise in the FDP since the euglobulin lysis time was normal.
It is now well recognized that certain physiological changes occur in the coagulation and fibrinolytic mechanisms during the course of a normal pregnancy, and that these lead to an increased capacity to deposit intravascular fibrin with a reduction in spontaneous fibrinolysis (Bonnar, McNicol, and Douglas, 1969) . Reduced plasma fibrinogen levels have, in consequence, been reported during and shortly after delivery in normal women, the lowest values occuring approximately four hours after parturition with a subsequent rise; increased levels of FDP at this time suggest that thromboplastic material liberated at the placental site and entering the maternalcirculationrincreases intravascularcoagulation for a brief period (Kleiner, Merskey, Johnson, and Markus, 1970) . Our patient had suffered none of the complications ofpregnancy, such as preeclampsia specifically associated with pathologically increased intravascular coagulation. Although no assessment of the coagulation status was carried out before delivery, it seems probable that the sustained massive increase in FDP and the persistent postpartum hypofibrinogenaemia were due to intravascular coagulation following the release of tissue thromboplastins during hepatocellular necrosis with a component contribution from the placental site.
It is well known that fibrin deposition and vascular occlusion within the placenta may result in placental insufficiency whilst renal vascular fibrin deposition may be of importance in the pathogenesis of renal failure in the postpartum period (Luke, Siegel, Talbert, and Holland, 1970 It would seem that intravascular coagulation, whether occurring physiologically or as a result of hepatic cell necrosis, may in itself adversely prejudice the recovery of the patient. The absence of vascular thrombi in the biopsy specimen is in keeping with previously reported experience (Merskey, Johnson, Kleiner, and Wahl, 1967) although Rake and his colleagues (1971) do record this. This may reflect the adequacy of heparin therapy in preventing and/or treating the intravascular coagulation. It is also tempting to postulate that the dramatic improvement in the mental state was due to the effect of therapy on small vessel thrombi in the cerebral circulation.
Although patients with acute viral hepatitis commonly have evidence of impaired hepatic synthesis of coagulation factors, the presence of marked intravascular coagulation with platelet and fibrinogen consumption justifies the controlled use of heparin when there is minimal evidence of synthetic failure. The possibility that fibrin deposition and vascular occlusion intensify the degree of hepatic cell necrosis, particularly in situations where intravascular coagulation is already physiologically increased, are added reasons for considering heparin therapy. 
